VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener
ScreenerThemes
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
Earnings
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Pharma & Energy
LLY vs NVOJNJ vs PFEXOM vs CVX
Compare Any Stocks...
WatchlistInsider
ScreenerThemes
Earnings
WatchlistInsider
SGRY
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Verify deeply. Act with conviction.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly stock ideas — free

© 2026 VCP Scanner
AboutPrivacyTerms
Not financial advice. Do your own research.
ScreenerNewsCompareWatchlist
SGRYSurgery Partners, Inc.
$16.56$2.2B
Overview & Verdict
Overview
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice HistoryTechnical Analysis
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Ownership
Holders
HomeStocksSGRYBalance Sheet

Surgery Partners, Inc. (SGRY) Balance Sheet

13Y historyFree accessUpdated daily

The company's financial leverage remains a primary concern, with the debt-to-equity ratio climbing to 1.16 and a deepening retained earnings deficit of $851.1 million as of 2026Q1.

SGRY Balance Sheet

Income StatementBalance SheetCash FlowRatios
AnnualQuarterly
MetricTTMDec'25Dec'24Dec'23Dec'22Dec'21Dec'20Dec'19Dec'18Dec'17Dec'16Dec'15Dec'14Dec'13
Total Current Assets1.08B1.15B1.12B895M921M946.1M801.5M525.5M588.32M563.23M361.95M310.96M268.65M82.51M
Cash & Short-Term Investments182.3M239.9M269.5M195.9M282.9M389.9M317.9M92.7M184.31M174.91M69.7M57.93M74.92M13.03M
Cash Only182.3M239.9M269.5M195.9M282.9M389.9M317.9M92.7M184.31M174.91M69.7M57.93M74.92M13.03M
Short-Term Investments00000000000000
Accounts Receivable603.4M602.2M579.1M496.4M456.3M430.2M382.2M326.9M316.14M295.62M227.64M186.19M153.63M62.49M
Days Sales Outstanding64.0866.4367.8766.0565.5970.577565.1565.1480.4572.5470.8139.0580.15
Inventory100.5M96.6M88.4M75.2M71.4M61.1M56.4M46.3M43.36M44.95M28.78M25.59M23.69M4.57M
Days Inventory Outstanding13.3213.8613.6213.113.2712.8613.9112.0111.6316.1812.7913.9634.029.82
Other Current Assets157.5M170.9M182.4M96.5M79M39.3M27.4M41.8M28.28M30.9M24.68M33.83M18.03M8.95M
Total Non-Current Assets6.96B7.09B6.77B5.98B5.76B5.17B4.61B4.49B4.09B4.06B1.94B1.8B1.59B392.19M
Property, Plant & Equipment1.42B1.44B1.38B1.22B1.16B953.8M854.7M821M426.29M398.54M204.25M184.55M175.01M20.8M
Fixed Asset Turnover2.33x2.29x2.25x2.24x2.20x2.33x2.18x2.23x4.16x3.37x5.61x5.20x2.30x13.68x
Goodwill05.19B5.07B4.33B4.14B3.91B3.47B3.4B3.38B3.35B1.56B1.41B1.3B339.52M
Intangible Assets5.25B41M45.7M54.8M42.3M43.7M46.9M47.3M54.29M58.91M48.02M53.57M54.89M26.98M
Long-Term Investments909M234M215.4M184.1M190.3M88.7M90.3M93.2M78.48M74.28M34.98M34.1M33.44M0
Other Non-Current Assets72.8M56.8M57.5M103.3M144.2M59.1M27M30.8M36.85M48.66M16.75M21.47M24.28M4.89M
Total Assets8.04B8.24B7.89B6.88B6.68B6.12B5.41B5.02B4.68B4.62B2.3B2.11B1.86B474.7M
Asset Turnover0.42x0.40x0.39x0.40x0.38x0.36x0.34x0.36x0.38x0.29x0.50x0.46x0.22x0.60x
Asset Growth %17.33%4.46%14.74%2.91%9.23%13.01%7.86%7.33%1.16%100.56%9.41%13.34%291.57%-
Total Current Liabilities581.7M615.5M624.4M523M493.4M536.8M556.8M398.1M349.3M303M186.72M181.31M141.39M42.45M
Accounts Payable168.6M208.7M208.7M171.8M151.6M124.9M100.2M96.7M83.29M84.71M49.77M45.34M43.06M18.28M
Days Payables Outstanding25.729.9532.1629.9228.1726.324.7125.0722.3330.522.1224.7361.8439.28
Short-Term Debt142.6M142M101.4M73.3M62.8M60.4M64.4M56M55.6M58.73M27.82M27.27M22.09M8.84M
Deferred Revenue (Current)00003.2M64.4M109.8M0-138.84M-143.44M-77.59M-72.61M58.98M0
Other Current Liabilities193.4M199.9M24.8M23.9M49.1M47.3M38.1M22.5M135.19M19.48M25.71M49.38M24.37M4.33M
Current Ratio1.86x1.87x1.79x1.71x1.87x1.76x1.44x1.32x1.68x1.86x1.94x1.72x1.90x1.94x
Quick Ratio1.69x1.71x1.65x1.57x1.72x1.65x1.34x1.20x1.56x1.71x1.78x1.57x1.73x1.84x
Cash Conversion Cycle51.750.3549.3349.2250.6957.1464.252.0854.4366.1463.2160.03111.2350.68
Total Non-Current Liabilities3.98B4.1B3.63B2.99B2.91B3.28B3.23B2.92B2.54B2.98B1.61B1.44B1.5B446.62M
Long-Term Debt2.73B2.71B3.27B2.7B2.56B2.88B2.79B2.52B2.25B2.13B1.41B1.22B1.39B418.56M
Capital Lease Obligations3.73B1.18B292.1M248.9M271.4M315.6M300.9M283.1M166.34M121.63M07.15M-18.18M0
Deferred Tax Liabilities307.8M175.7M39.2M0000052.28M28.38M122.35M63.99M49.17M16.02M
Other Non-Current Liabilities41.6M41.2M30.2M41.1M75.4M87M139.7M113.6M121.49M100.85M198.62M211.46M35.48M12.04M
Total Liabilities4.56B4.72B4.25B3.51B3.4B3.82B3.79B3.32B4.68B4.62B2.3B2.11B1.64B489.08M
Total Debt4.03B4.02B3.7B3.06B2.93B3.29B3.2B2.9B2.48B2.19B1.5B1.31B1.41B427.4M
Net Debt3.85B3.78B3.43B2.87B2.65B2.9B2.88B2.81B2.29B2.01B1.43B1.26B1.34B414.38M
Debt / Equity1.16x1.14x1.02x0.91x0.89x1.43x1.97x1.71x2.25x1.64x4.61x4.41x6.37x-
Debt / EBITDA7.05x7.12x7.39x6.86x6.37x8.22x11.51x9.29x17.04x10.42x6.34x7.33x21.48x6.12x
Net Debt / EBITDA6.73x6.69x6.85x6.42x5.75x7.24x10.36x8.99x15.78x9.58x6.05x7.00x20.34x5.93x
Interest Coverage1.35x1.43x1.73x1.70x1.47x1.37x0.91x1.31x0.53x1.70x2.05x0.25x0.82x2.16x
Total Equity3.48B3.53B3.64B3.36B3.28B2.3B1.62B1.7B1.1B1.34B324.67M297.93M222.13M-14.38M
Equity Growth %-6.87%-2.98%8.13%2.41%42.75%41.67%-4.47%54.64%-17.78%311.68%8.98%34.13%1645.22%-
Book Value per Share27.1227.7228.8226.7635.7031.7533.2835.2022.8827.286.747.954.61-0.30
Total Shareholders' Equity1.69B1.71B1.79B1.99B2B1.09B550.1M691.8M404.64M654.73M9.68M-4.03M-264.08M-103.62M
Common Stock1.3M1.3M1.3M1.3M1.3M900K500K500K489K487K485K482K00
Retained Earnings-851.1M-815.2M-737.3M-569.2M-557.3M-502.7M-431.8M-315.7M-247.02M-41.32M-311.35M-320.8M-322.23M-163.34M
Treasury Stock0000000033K00000
Accumulated OCI-10.5M-13.8M4.8M57.5M76.2M-31.5M-61M-50.7M-22.45M-19.68M-86.39M-70.24M-55.7M-17.19M
Minority Interest1.79B1.81B1.85B1.37B1.28B1.21B1.07B1.01B694.3M681.88M315M301.95M486.21M89.24M

Key Metrics

Growth RegimeDecelerating
ProfitabilityNegative
Balance SheetStrained
Cash FlowMixed
Top Statement Risk

High Debt-to-Equity Burden

Verified Source

Metrics are mathematically derived from official filings.

SEC 10-K (2026Q1)

Leverage Pressures Limit Financial Flexibility

As reported in recent financial statements, SGRY's debt-to-equity ratio has climbed steadily from 0.91 in 2023Q4 to 1.16 by 2026Q1, indicating that the company's reliance on debt-funded acquisitions is increasingly straining its capital structure and potentially limiting its future strategic maneuverability in a volatile rate environment.

The consistent rise in the debt-to-equity ratio suggests that the company is prioritizing inorganic growth over balance sheet deleveraging. Investors should monitor whether this leverage trajectory remains sustainable, as the persistent reliance on debt to fund facility acquisitions may heighten refinancing risks if interest rates remain elevated.

Goodwill Dominates Asset Composition Profile

Based on the company's balance sheet data, goodwill has expanded from $4.3 billion in 2023Q4 to $5.2 billion in 2026Q1, representing a significant portion of total assets and suggesting that the firm's valuation is heavily dependent on the successful integration of past and future facility acquisitions.

The concentration of goodwill within the asset base implies that the company's book value is highly sensitive to potential impairment charges if acquired facilities fail to meet performance expectations. This asset-heavy structure warrants further investigation into the underlying cash-generating capacity of these acquired units relative to their carrying values.

Cash Buffer Remains Relatively Thin

According to quarterly filings, SGRY's cash position has fluctuated significantly, dropping to $182.3 million in 2026Q1 from a peak of $269.5 million in 2024Q4, which may indicate a tightening liquidity buffer as the company navigates ongoing operational costs and debt service requirements in a challenging market.

While the current ratio remains above 1.8, the absolute cash levels appear modest relative to the company's scale and debt obligations. This suggests that the firm may have limited room for error should working capital requirements or unexpected operational headwinds necessitate additional liquidity in the near term.

Retained Earnings Deficit Signals Challenges

As indicated by the company's balance sheet, the deficit in retained earnings has deepened from -$569.2 million in 2023Q4 to -$851.1 million in 2026Q1, reflecting a persistent inability to generate cumulative net profitability despite the company's aggressive expansion and revenue growth efforts over the last ten quarters.

The widening deficit in retained earnings suggests that the company's core operations are not yet producing sufficient bottom-line results to offset historical losses. This trend may indicate that the current business model requires significant structural adjustments to achieve long-term equity value creation for shareholders.

SGRY — Frequently Asked Questions

Quick answers to the most common questions about buying SGRY stock.

What are the total assets of Surgery Partners, Inc. (SGRY)?

As of 2025, Surgery Partners, Inc. (SGRY) had total assets of $8.24B including $1.15B in current assets.

How much debt does Surgery Partners, Inc. (SGRY) have?

Surgery Partners, Inc. (SGRY) carries total debt of $4.02B, offset by $239.9M in cash and short-term investments. Comparing total debt to cash helps evaluate the company's debt burden and net leverage.

What is the book value or shareholders' equity of Surgery Partners, Inc.?

Surgery Partners, Inc. (SGRY) has total shareholders' equity (book value) of $1.71B ($27.72 book value per share). Book value represents the net worth of the company belonging to common stock holders.

What is Surgery Partners, Inc.'s current ratio and liquidity?

Surgery Partners, Inc. (SGRY) reported a current ratio of 1.87x. A current ratio above 1.0x indicates that the company has more current assets than current liabilities, suggesting sufficient short-term liquidity.